Literature DB >> 25145801

Healthy decisions: towards uncertainty tolerance in healthcare policy.

Janneke P C Grutters1, Marjolein B A van Asselt, Kalipso Chalkidou, Manuela A Joore.   

Abstract

Mesh：

Year:  2015        PMID： 25145801     DOI： 10.1007/s40273-014-0201-7

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN： 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  13 in total

1.  In risk assessment, one has to admit ignorance.

Authors:  Holger Hoffmann-Riem; Brian Wynne
Journal:  Nature       Date:  2002-03-14       Impact factor: 49.962

2.  Well informed uncertainties about the effects of treatments.

Authors:  Iain Chalmers
Journal:  BMJ       Date:  2004-02-28

3.  When to wait for more evidence? Real options analysis in proton therapy.

Authors:  Janneke P C Grutters; Keith R Abrams; Dirk de Ruysscher; Madelon Pijls-Johannesma; Hans J M Peters; Eric Beutner; Philippe Lambin; Manuela A Joore
Journal:  Oncologist       Date:  2011-12-06

4.  Expected value of information and decision making in HTA.

Authors:  Simon Eckermann; Andrew R Willan
Journal:  Health Econ       Date:  2007-02       Impact factor: 3.046

5.  A rational framework for decision making by the National Institute For Clinical Excellence (NICE).

Authors:  Karl Claxton; Mark Sculpher; Michael Drummond
Journal:  Lancet       Date:  2002-08-31       Impact factor: 79.321

6.  Scientific peer review to inform regulatory decision making: a European perspective.

Authors:  Ragnar Lofstedt; Robyn Fairman
Journal:  Risk Anal       Date:  2006-02       Impact factor: 4.000

7.  Rationing new medicines in the UK.

Authors:  Michael Drummond; Anne Mason
Journal:  BMJ       Date:  2009-01-22

8.  Evidence-based decision making: when should we wait for more information?

Authors:  Kalipso Chalkidou; Joanne Lord; Alastair Fischer; Peter Littlejohns
Journal:  Health Aff (Millwood)       Date:  2008 Nov-Dec       Impact factor: 6.301

9.  Model parameter estimation and uncertainty analysis: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force Working Group-6.

Authors:  Andrew H Briggs; Milton C Weinstein; Elisabeth A L Fenwick; Jonathan Karnon; Mark J Sculpher; A David Paltiel
Journal:  Med Decis Making       Date:  2012 Sep-Oct       Impact factor: 2.583

Review 10.  Acknowledging patient heterogeneity in economic evaluation : a systematic literature review.

Authors:  Janneke P C Grutters; Mark Sculpher; Andrew H Briggs; Johan L Severens; Math J Candel; James E Stahl; Dirk De Ruysscher; Albert Boer; Bram L T Ramaekers; Manuela A Joore
Journal:  Pharmacoeconomics       Date:  2013-02       Impact factor: 4.981
View more
  9 in total

1.  The Authors' Reply: Comment on "Healthy Decisions: Towards Uncertainty Tolerance in Healthcare Policy".

Authors:  Janneke P C Grutters; Marjolein B A van Asselt; Kalipso Chalkidou; Manuela A Joore
Journal:  Pharmacoeconomics       Date:  2015-09       Impact factor: 4.981

2.  Comment on: "Healthy Decisions: Towards Uncertainty Tolerance in Healthcare Policy".

Authors:  Afschin Gandjour
Journal:  Pharmacoeconomics       Date:  2015-09       Impact factor: 4.981

3.  Exploring Uncertainty in Economic Evaluations of Drugs and Medical Devices: Lessons from the First Review of Manufacturers' Submissions to the French National Authority for Health.

Authors:  Salah Ghabri; Françoise F Hamers; Jean Michel Josselin
Journal:  Pharmacoeconomics       Date:  2016-06       Impact factor: 4.981

Review 4.  The Australian Managed Entry Scheme: Are We Getting it Right?

Authors:  Haitham W Tuffaha; Paul A Scuffham
Journal:  Pharmacoeconomics       Date:  2018-05       Impact factor: 4.981

Review 5.  The development of scientific evidence for health policies for obesity: why and how?

Authors:  M B Richardson; M S Williams; K R Fontaine; D B Allison
Journal:  Int J Obes (Lond)       Date:  2017-03-15       Impact factor: 5.095

6.  Development and Validation of the TRansparent Uncertainty ASsessmenT (TRUST) Tool for Assessing Uncertainties in Health Economic Decision Models.

Authors:  Sabine E Grimm; Xavier Pouwels; Bram L T Ramaekers; Ben Wijnen; Saskia Knies; Janneke Grutters; Manuela A Joore
Journal:  Pharmacoeconomics       Date:  2020-02       Impact factor: 4.981

7.  Preferences for engagement in health technology assessment decision-making: a nominal group technique with members of the public.

Authors:  Sally Wortley; Allison Tong; Kirsten Howard
Journal:  BMJ Open       Date:  2016-02-01       Impact factor: 2.692

8.  Value of Information Analysis Informing Adoption and Research Decisions in a Portfolio of Health Care Interventions.

Authors:  Haitham W Tuffaha; Louisa G Gordon; Paul A Scuffham
Journal:  MDM Policy Pract       Date:  2016-07-07

9.  Problems and Promises of Health Technologies: The Role of Early Health Economic Modeling.

Authors:  Janneke P C Grutters; Tim Govers; Jorte Nijboer; Marcia Tummers; Gert Jan van der Wilt; Maroeska M Rovers
Journal:  Int J Health Policy Manag       Date:  2019-10-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.